Tiocla Inj. 1.6g
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Category
- Pharmaceuticals
Vine & Co,
- Verified Certificate
-
10
Product name | Tiocla Inj. 1.6g | Certification | - |
---|---|---|---|
Category | Pharmaceuticals | Ingredients | - |
Keyword | ticarcillin disodium , pennicillin , antibioitcs , clavulanate potassium | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | South Korea | Stock | - |
Supply type | - | HS code | - |
Product Information
TIOCLA Inj. 1.6g/ 3.2g
Ticarcillin with Clavulanic acid
category : Penicillin, Antibiotic and Antimicrobial Agents
This is the antibiotic recommended by Sanford Guide.
We have the right of the exclusive sale for TIOCLA.
TIOCLA is the ticarcillin with clavulanic acid.
It is appropriate initial therapy when you suspect
B-lactamase-producing pathogens.
- Indications
1.Skin and skin structure infections:
-Diabetic foot infections (non-limb-or life-threatening)
-Extremity wounds accompanied by fever and sepsis
-Infected human bites
2.Intra-abdominal infections:
-Peritonitis secondary to ruptured appendix, bowel perforation
or ruptured diverticula (for mild or moderate disease)
-Spontaneous bacterial peritonitis
3.Bone and joint infections:
-Contiguous osteomyelitis with severe vascular insufficiency in
hospitalized patients with neurologic deficit and decubiti,
atherosclerotic peripheral vascular disease, or diabetes with neuropathy
4.Urinary tract infections:
-Complicated urinary tract infection
5.Septicemia:
-Postoperative infections with sepsis
1. Over 127 million doses, 21 years of clinical use
2. Safety demonstrated in children as young as 3 months
3. Indicated daily dosage contains 1.3g sodium(q6h), which falls within
American Heart Association guidelines for sodium intake of 2.4g/day
4. No dosage adjustments in patients with hepatic insufficiency alone
This is our exclusive antibiotic in Korea.
Tiocla is made of Ticarcillin with Clavulanate (B-lactamase inhibitor).
This is better than 3rd Generation of cephalosporins about wide spectrum,
low side effect and tolerance.
We can supply it as much as you want.
Please contact us, if you are interested with this amazing antibiotic.
- Product Info Attached File
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Sung Geun Kim
- Address
- 5th floor, Bang-ju building, 15, Gudeok-ro 321beon-gil, Seo-gu, Busan, Korea, 602-819
- Product Category
- Medical Services,Pharmaceuticals
- Year Established
- 2006
- Company introduction
-
ine & Co.
Spreading the Joy of Health
‘Share makes joy double and sorrow half.’2014. 06 Conversion to a corporation..
2010. 09 Changing our company’s name to Vine & Co.
2010. 01 Certied the Corp research institute.
2008. 07 Concluding an agreement with Boston Scientic Co.
2008. 05 Establishing BioVIm, Inc. in America (100% Investment)
2008. 03 Concluding an agreement with Pharmalink, Invida
2007. 07 Concluding an agreement with Jae-il pharm.
2007. 02 Opeing an order for the rst time in Busan and Kyeong-Nam University hospital
2007. 01 Concluding an agreement with KoreaWyeth
2007. 01 Certied KGSP(Korean Good Supplying Practices)
2006. 08 Establishing Vine pharm.
- Main Product